MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


IN BRIEF: Abcam interim profit falls by 20% as expenses rise

ALN

Abcam PLC - Cambridge-based life science research software firm - Posts lower profit for six months that ended June 30 as expenses increase. Pretax profit falls 20% to £7.4 million from £9.2 million a year prior. Revenue climbs 23% to £185.2 million from £150.2 million. Selling, general and administrative expenses rise by 28% to £137.3 million from £107.2 million. Research and development costs increase 72% to £19.1 million from £11.1 million.

Commenting on the future, Chief Executive Officer Alan Hirzel says: ‘As we move into the next phase of our five-year strategic plan, we are moderating investment levels and working toward higher operating leverage and adjusted operating margin expansion. Looking ahead, we are confident in our growth trajectory and committed to delivering our 2022 guidance and 2024 goals.’

Abcam expects revenue to increase by about 20% at constant exchange rates for all of 2022, with organic constant exchange rates growth in the mid-teens range. Further, it anticipates BioVision Inc, which it bought for $340 million in October 2021, to contribute to a continuing increase in adjusted operating margins. BioVision is a distributor of life science research tools to biopharma, diagnostic and academic customers.

Current stock price: 1,288.20 pence

12-month change: down 12%

Copyright 2022 Alliance News Limited. All Rights Reserved.